Refine Results
  1. "Michel Sadelain"
Formats
  1. Meeting Abstract (260)
  2. Journal Article (256)
  3. Conference Paper (3)
  4. Research Letter (3)
  5. Book Section (2)
  6. Editorial (2)
  7. Review (2)
Groups
  1. Center for Hematologic Malignancies (528)
  2. Department of Medicine (528)
  3. GSK Faculty (528)
  4. Hematologic Malignancies Research (528)
  5. Hematologic Malignancies, Division of (528)
  6. Molecular Pharmacology and Chemistry Program Faculty (528)

More Groups

People
  1. Michel Sadelain (528)
  2. Isabelle Riviere (182)
  3. Renier Brentjens (111)
  4. Xiuyan Wang (78)
  5. Jae Park (66)
  6. Richard O'Reilly (34)

More People

Years
  1. 2022 (5)
  2. 2021 (21)
  3. 2020 (11)
  4. 2019 (26)
  5. 2018 (28)
  6. 2017 (26)

More Years

Publications
  1. Blood (113)
  2. Molecular Therapy (51)
  3. Cancer Research (23)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Blood Cells, Molecules, and Diseases (12)

More Publications

Publishers
  1. American Society of Hematology (113)
  2. Nature Publishing Group (109)
  3. Elsevier Inc. (48)
  4. American Association for Cancer Research (43)
  5. American Society of Clinical Oncology (19)
  6. Elsevier Science, Inc. (15)

More Publishers

Results (528)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors for targeting tumors with low antigen density
    Journal Article

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A. E.; Li, Z.; Sjöstrand, M.; Lindenbergh, P. L.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
    Review

    Morris, E. C.; Neelapu, S. S.; Giavridis, T.; Sadelain, M.
    Nature Reviews Immunology (2022)

    Fulltext@MSK | Save
  • Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: A phase 1 trial
    Journal Article

    Boulad, F.; Maggio, A.; Wang, X.; Moi, P.; Acuto, S.; Kogel, F.; Takpradit, C.; Prockop, S.; Mansilla-Soto, J.; Cabriolu, A.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: A preclinical model and initial clinical experience
    Journal Article

    Palomba, M. L.; Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Rivière, I.; Sadelain, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors effectively target low abundance antigens
    Meeting Abstract

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A.; Li, Z.; Sjöstrand, M.; Lindenbergh, P.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
    Journal Article

    Katsarou, A.; Sjöstrand, M.; Naik, J.; Mansilla-Soto, J.; Kefala, D.; Kladis, G.; Nianias, A.; Ruiter, R.; Poels, R.; Sarkar, I.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Rojas, L. A.; Łuksza, M.; Sethna, Z. M.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save